← SynDRA
CETABEN
SynDRA canonical compound SYN0001717 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | PPARA |
|---|
| Mechanism of action | ACAT inhibitor | cholesterol inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- ACAT inhibitor
- cholesterol inhibitor
Cross-references
Synonyms
- Benzoic acid, 4-(hexadecylamino)-
- P-(hexadecylamino)benzoate
- 4-(Hexadecylamino)benzoic acid
- Cetabenum
- 4-(hexadecylamino)-benzoic acid
- Hexadecylamino-p-amino Benzoic Acid
- DTL5W0113X
- p-hexadecylaminobenzoate sodium
- sodium p-hexadecylaminobenzoate
- cetaben, monosodium salt
- Benzoic acid, 4-(hexadecylamino)-, monosodium salt
- RefChem:124681
- DTXCID00127049
- sodium 4-(hexadecylamino)benzoate
- Cetaben [INN]
- 4-(n-Hexadecylamino)benzoic acid
- Cetabeno
- Cetabenum [INN-Latin]
- Cetabeno [INN-Spanish]
- SR-01000944982
- BRN 2748166
- UNII-DTL5W0113X
- Cetaben (free base)
- p-hexadecylaminobenzoic acid
- 4(hexadecylamino)benzoic acid
- 4-n-hexadecylaminobenzoic acid
- orb1308464
- SCHEMBL2112078
- QXWKHSSBFQDQPR-UHFFFAOYSA-N
- 4-(n-hexadecylamino)-benzoic acid
- HMS3650E11
- MFCD00865766
- AKOS032947282
- NCGC00261985-01
- BP-42541
- MS-25733
- DB-052834
- HY-119964
- CS-0078843
Look up CETABEN in the interactive SynDRA portal →